Dr Sumith Harindranath

Dr Sumith Harindranath has extensive work experience in the field of pharmacovigilance and medical writing. Dr Sumith started their career in 2009 as a Senior Process Associate at Tata Consultancy Services, where they triaged, processed, and quality reviewed individual case safety reports. Dr Sumith also served as a point of contact for case processing queries.

In 2013, Dr Harindranath was promoted to the role of Business Process Lead - Pharmacovigilance Scientist at Tata Consultancy Services. In this position, they performed safety periodic writing, including assessment, analysis, and quality control of various reports. Dr Sumith also conducted peer reviews and Pre-DLP activities.

After working at Tata Consultancy Services, Dr Harindranath joined iMEDGlobal Corporation in 2015 as a Specialist - Medical Writing. During their time there, they led the preparation of global periodic safety reports for newly launched products and ensured compliance with regulatory requirements. Dr Sumith also provided support in addressing Health Authority comments.

In 2016, Dr Harindranath joined Pfizer as a Manager. Here, they created documents related to clinical and post-marketing safety data to support product development and licensing applications. Dr Sumith also led a team of authors and coordinated with regulatory authorities.

Currently, Dr Harindranath is working at Taiho Oncology, Inc. Dr Sumith initially joined as a Manager, PV Sciences in 2021 and was later promoted to the role of Senior Manager in 2023. Further details about their responsibilities in this role are not available.

Dr Sumith Harindranath's education history is as follows:

Dr Sumith attended New England College from 2019 to 2020, where they obtained a Master of Science (MS) degree in Medical Informatics.

In 2011 to 2012, they attended Newcastle University and completed a Master of Business Administration (MBA) with a specialization in General MBA.

In 2008 to 2009, they pursued a Post-Graduate Certificate in Clinical Research at the Institute of Clinical Research India.

From 2000 to 2006, Dr Sumith Harindranath studied at Tamil Nadu Dr. M.G.R. Medical University in Chennai and earned a Bachelor of Dental Surgery (BDS) degree specializing in Dentistry.

In 1998 to 2000, they completed their secondary education at Matha Senior Secondary School in Kerala, obtaining a Central Board of Secondary Education (CBSE) degree.

Dr Sumith Harindranath attended Indian School Muscat in 1997 to 1998 and completed the Xth grade.

In addition to their formal education, they have obtained several additional certifications. In October 2019, they completed certifications in Scrum: The Basics from LinkedIn, Signal Detection and Causality Assessment from the World Health Organization, and ICH GCP from The National Institute on Drug Abuse (NIDA).